Abstract:

BACKGROUND: Small-scale studies have shown that low-dose, intermittent application of parathyroid hormone related peptide can effectively treat osteoporosis in postmenopausal women. But it is disadvantageous due to prone to degrade, short half-life and expensive cost, therefore it is necessary to modulate the release speed of parathyroid hormone related peptide using controlled-release system and to improve the biological efficiency.
OBJECTIVE: To prepare a novel nanoparticles for carrying drugs, and to investigate encapsulation efficiency and in vitro release characteristics of parathyroid hormone-related peptide.
METHODS: Quaternary ammonium salt of chitosan nanoparticles were prepared based on ionic gelation, and the characteristics were observed by fourier transform infrared spectroscopy and transmission electron microscopy, and the encapsulation efficiency and release characteristics in vitro of the nanoparticles were determined.
RESULTS AND CONCLUSION: Chitosan quaternary ammonium salt and sodium tripolyphosphate were mixed to form the nanoparticles when the quantity of chitosan quaternary ammonium salt and sodium tripolyphosphate was 5:1-2:1 under stirring at room temperature. The nanoparticles size was about 100-180 nm, regular sphere. With the increase of the parathyroid hormone-related peptide concentration, the drug encapsulation efficiency increased but the loading capacity reduced. The drug-loading nanoparticles showed slow release characteristics in PBS solution in vitro.